Cleared Traditional

DIASAFEplusUS (F00013010)

K251851 · Fresenius Medical Care Renal Therapies Group, LLC · Gastroenterology & Urology
Oct 2025
Decision
115d
Days
Class 2
Risk

About This 510(k) Submission

K251851 is an FDA 510(k) clearance for the DIASAFEplusUS (F00013010), a Subsystem, Water Purification (Class II — Special Controls, product code FIP), submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on October 9, 2025, 115 days after receiving the submission on June 16, 2025. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5665.

Submission Details

510(k) Number K251851 FDA.gov
FDA Decision Cleared SESE
Date Received June 16, 2025
Decision Date October 09, 2025
Days to Decision 115 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code FIP — Subsystem, Water Purification
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.5665

Similar Devices — FIP Subsystem, Water Purification

All 116
AquaC UNO H
K250471 · Fresenius Medical Care Renal Therapies Group, LLC · Nov 2025
AquaA
K252181 · Fresenius Medical Care North America · Sep 2025
UPT Series Medical RO Water Treatment System
K250514 · Specialty Water Technologies, Inc. · Mar 2025
AquaBplus; AquaB LITE
K232953 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 2024
AQUAbase nX
K223479 · B.Braun Medical, Inc. · Aug 2023
RenaPure Endotoxin Retentive Filter
K231410 · Evoqua Water Technologies, LLC · Jul 2023